Immunome, Inc. (IMNM)
18.65
-0.71
(-3.67%)
USD |
NASDAQ |
Nov 10, 16:00
18.65
0.00 (0.00%)
After-Hours: 20:00
Immunome Cash from Operations (Annual) : -190.92M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -190.92M |
| December 31, 2024 | -110.79M |
| December 31, 2023 | -7.568M |
| December 31, 2022 | -28.69M |
| Date | Value |
|---|---|
| December 31, 2021 | -18.23M |
| December 31, 2020 | -12.13M |
| December 31, 2019 | -9.60M |
| December 31, 2018 | -7.406M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Revolution Medicines, Inc. | -897.74M |
| Erasca, Inc. | -95.46M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |